The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1345
August 23, 2010
View Complete Issue         Table of Contents 2019 
Three New Drugs for Hereditary Angioedema
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Three New Drugs for Hereditary Angioedema
August 23, 2010 (Issue: 1345)
In the past 2 years, the FDA has approved 3 new drugs for prevention or treatment of hereditary angioedema (HAE) in non-pregnant adolescents and adults: the C1 esterase inhibitor Cinryze for prophylaxis and the C1 esterase inhibitor Berinert and the...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Three New Drugs for Hereditary Angioedema
Article code: 1345b
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.